These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 10573211

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Species-dependent stereoselective drug binding to albumin: a circular dichroism study.
    Pistolozzi M, Bertucci C.
    Chirality; 2008 Mar; 20(3-4):552-8. PubMed ID: 18172833
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic evaluation of mannosylated bovine serum albumin as a liver cell-specific carrier: quantitative comparison with other hepatotropic ligands.
    Ogawara K, Hasegawa S, Nishikawa M, Takakura Y, Hashida M.
    J Drug Target; 1999 Mar; 6(5):349-60. PubMed ID: 10342383
    [Abstract] [Full Text] [Related]

  • 6. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.
    Wosikowski K, Biedermann E, Rattel B, Breiter N, Jank P, Löser R, Jansen G, Peters GJ.
    Clin Cancer Res; 2003 May; 9(5):1917-26. PubMed ID: 12738750
    [Abstract] [Full Text] [Related]

  • 7. Influence of structure of human, rat, and bovine serum albumins on binding properties of photoactive drug hypericin.
    Hritz J, Kascakova S, Ulicny J, Miskovsky P.
    Biopolymers; 2002 May; 67(4-5):251-4. PubMed ID: 12012440
    [Abstract] [Full Text] [Related]

  • 8. Enhanced uptake of lactosaminated human albumin by rat hepatocarcinomas: implications for an improved chemotherapy of primary liver tumors.
    Di Stefano G, Fiume L, Bolondi L, Lanza M, Pariali M, Chieco P.
    Liver Int; 2005 Aug; 25(4):854-60. PubMed ID: 15998437
    [Abstract] [Full Text] [Related]

  • 9. Transient absorption spectroscopy for determining multiple site occupancy in drug-protein conjugates. A comparison between human and bovine serum albumins using flurbiprofen methyl ester as a probe.
    Vayá I, Jiménez MC, Miranda MA.
    J Phys Chem B; 2008 Mar 06; 112(9):2694-9. PubMed ID: 18266356
    [Abstract] [Full Text] [Related]

  • 10. The loading rate determines tumor targeting properties of methotrexate-albumin conjugates in rats.
    Stehle G, Sinn H, Wunder A, Schrenk HH, Schütt S, Maier-Borst W, Heene DL.
    Anticancer Drugs; 1997 Aug 06; 8(7):677-85. PubMed ID: 9311444
    [Abstract] [Full Text] [Related]

  • 11. Lactosaminated human albumin, a hepatotropic carrier of drugs.
    Fiume L, Di Stefano G.
    Eur J Pharm Sci; 2010 Jul 11; 40(4):253-62. PubMed ID: 20403430
    [Abstract] [Full Text] [Related]

  • 12. Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells.
    Ulbrich K, Michaelis M, Rothweiler F, Knobloch T, Sithisarn P, Cinatl J, Kreuter J.
    Int J Pharm; 2011 Mar 15; 406(1-2):128-34. PubMed ID: 21185364
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. III. Human serum albumin-methotrexate derivative, its preparation and basic testing.
    Bures L, Bostík J, Motycka K, Spundová M, Rehák L.
    Neoplasma; 1988 Mar 15; 35(3):329-42. PubMed ID: 3405341
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. S-Nitrosated human serum albumin dimer is not only a novel anti-tumor drug but also a potentiator for anti-tumor drugs with augmented EPR effects.
    Ishima Y, Chen D, Fang J, Maeda H, Minomo A, Kragh-Hansen U, Kai T, Maruyama T, Otagiri M.
    Bioconjug Chem; 2012 Feb 15; 23(2):264-71. PubMed ID: 22225412
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Albumin-coupled methotrexate (MTX-HSA) is a new anti-arthritic drug which acts synergistically to MTX.
    Fiehn C, Müller-Ladner U, Gay S, Krienke S, Freudenberg-Konrad S, Funk J, Ho AD, Sinn H, Wunder A.
    Rheumatology (Oxford); 2004 Sep 15; 43(9):1097-105. PubMed ID: 15199219
    [Abstract] [Full Text] [Related]

  • 19. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
    Chen P, Cameron R, Wang J, Vallis KA, Reilly RM.
    J Nucl Med; 2003 Sep 15; 44(9):1469-78. PubMed ID: 12960194
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.